---
company: HAWKINS INC
ticker: HWKN
form: 8-K
filed: 2026-05-13
accession: 0000046250-26-000017
source: https://www.sec.gov/Archives/edgar/data/46250/000004625026000017/
---

# Hawkins (HWKN) earnings release, May 13, 2026

Hawkins Inc (HWKN) · Form 8-K, Item 2.02 · Filed 2026-05-13 · [SEC filing](https://www.sec.gov/Archives/edgar/data/46250/000004625026000017/)

Hawkins, Inc. Reports

Fourth Quarter and Fiscal Year 2026 Results

ROSEVILLE, Minn., May 13, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 29, 2026.

Fourth Quarter Fiscal Year 2026 Highlights:

• Record fourth quarter sales of $265.9 million, an 8% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 16% over the same quarter in the prior year. All segments grew revenue in the fourth quarter 2026.

• Record fourth quarter gross profit of $54.2 million, a 4% increase over the same quarter of the prior year.

• Fourth quarter diluted earnings per share (EPS) of $0.74, a decrease of $0.04, or 5%, due primarily to an approximately $4.4 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including the largest, WaterSurplus, which closed in the first quarter of fiscal 2026. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have been 9% higher than the comparable prior year.

• Fourth quarter operating cash flow of $37.7 million, an increase of $6.9 million, or 22% over the same quarter in the prior year.

Full-Year Fiscal Year 2026 Highlights:

• Sales of approximately $1.1 billion, an increase of $109.3 million, or 11% from fiscal 2025.

• Gross profit of $245.1 million, an increase of $19.5 million, or 9% from fiscal 2025.

• Operating cash flow of $144.3 million, an increase of $33.2 million, or 30% from fiscal 2025.

• Diluted earnings per share (EPS) of $3.91, a decrease of $0.12, or 3%, from fiscal 2025, due primarily to an approximately $16.5 million increase in amortization, interest expense, and fair value accretion related to the earnout liability from the six acquisitions completed in fiscal 2026, including WaterSurplus. Assuming the acquisition of WaterSurplus had occurred at the beginning of the prior fiscal year, pro forma EPS would have increased by $0.32, or 9%, over the prior fiscal year.

• Net income was $81.5 million, while Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA), a non-GAAP measure, was $179.0 million, an increase of 6% over the prior fiscal year.

• Continued our acquisitions strategy and closed on six transactions during the fiscal year, mainly focused on accelerating growth in the Water Treatment segment.

• Paid cash dividends of $0.75 per share for the year, an increase of 7% over the prior year, marking our 41st consecutive year of paying a dividend.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Fiscal 2026 was another milestone year for our company, as we crossed $1 billion in revenue, for the first time in our history. My thanks to every person connected to our great company for helping us accomplish this goal. This achievement resulted in a number of records for the year; including sales, gross margin, operating income, and adjusted EBITDA.

Our focus has long been to deliver sustained growth over time, and we have continued to execute on that with pro forma EPS growth for the eighth consecutive year."

Mr. Hawkins continued, "Our disciplined M&A strategy remained a core competency for us and has again contributed to growth of Water Treatment, our largest reporting segment, which now represents 50% of our total company revenue and 56% of the total company operating income. We have completed 17 acquisitions over the last five years, most of which have helped to drive accelerated growth in our Water Treatment segment and we expect future acquisitions to continue to be focused on Water Treatment. With our latest deals, we now have a full product portfolio for our Water Treatment customers, including chemicals, media and filtration products, and equipment."

Mr. Hawkins continued, “Our Water Treatment segment achieved sales growth of 22% for the year, through sales from our acquired companies as well as organic growth. Sales in our Food and Health Sciences segment were relatively flat, mainly due to softness in the food and nutrition end markets, and our Industrial Solutions segment was up 6% for the year."

Mr. Hawkins concluded, “Looking ahead to fiscal 2027, we are well positioned to grow revenue and operating income in each of our business segments and expect EPS to grow as well. We expect our balance sheet to remain strong, and with the diversity of our businesses and the overall strength of our company, we believe we will continue to generate strong operating cash flow. This will allow us to fund future growth investments and continue to pay down our debt during fiscal year 2027 as we expect to achieve a leverage ratio of approximately 1x adjusted EBITDA by the end of fiscal year 2027.”

Fourth Quarter and Fiscal Year Financial Highlights:

NET INCOME

For the fourth quarter of fiscal 2026, the company reported net income of $15.5 million, or $0.74 per diluted share, compared to net income for the fourth quarter of fiscal 2025 of $16.3 million, or $0.78 per diluted share.

For the full year, the Company reported record net income of $81.5 million, or $3.91 per diluted share, compared to net income for fiscal 2025 of $84.3 million, or $4.03 per diluted share.

REVENUE... (truncated)0.3 million, or less than 1%, to $88.6 million for the fourth quarter, as compared to $88.3 million for the same period a year ago. Sales increased slightly with increased volumes of our Agricultural products, mostly offset by lower selling prices. Industrial Solutions segment sales increased $3.0 million, or 6%, to $55.0 million for the fourth quarter, as compared to $52.0 million for the same period a year ago. Sales increased primarily as a result of increased sales of certain of our manufactured, blended and repackaged products.

For fiscal 2026, sales were $1,083.7 million, an increase of $109.3 million, or 11%, from sales of $974.4 million a year ago. Water Treatment segment sales were $543.3 million for the year, an increase of 22% over last year’s sales of $446.5 million; of the $96.8 million increase, $83.3 million was from our acquired businesses in fiscal 2026. Sales for our Food and Health Sciences segment were $320.7 million in fiscal 2026, a decrease of 1%, from fiscal 2025 sales of $322.6 million. Industrial Solutions segment sales were $219.7 million, an increase of 7% from fiscal 2025 sales of $205.4 million.

GROSS PROFIT

Gross profit for fiscal 2026 increased $19.5 million, or 9%, to $245.1 million, or 23% of sales, from $225.5 million, or 23% of sales, for fiscal 2025. During fiscal 2026, the LIFO reserve increased, and gross profits decreased, by $1.5 million, of which $0.8 million occurred in the fourth quarter, primarily due to rising material costs. During fiscal 2025, the LIFO reserve decreased, and gross profit increased, by $1.6 million, most of which occurred in the fourth quarter. Gross profit increased due to increased sales, partially offset by the unfavorable year-over-year impact of the increased LIFO reserve.

Gross profit for the Water Treatment segment increased $23.2 million, or 19%, to $145.0 million, or 27% of sales, for fiscal 2026, from $121.8 million, or 27% of sales, for fiscal 2025. Gross profit increased as a result of the increased sales.

Gross profit for our Food and Health Sciences segment decreased $4.6 million, or 6%, to $67.3 million, or 21% of sales, for fiscal 2026, from $71.9 million, or 22% of sales, for fiscal 2025. Gross profit decreased as a result of lower selling prices as a result of competitive pricing pressures.

Gross profit for the Industrial Solutions segment increased $1.0 million, or 3%, to $32.8 million, or 15% of sales, for fiscal 2026, from $31.8 million, or 15% of sales, for fiscal 2025. Gross profit increased as a result of the increase in sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

SG&A expenses increased $17.4 million, or 16%, to $123.8 million, or 11% of sales, for fiscal 2026, from $106.4 million, or 11% of sales, for fiscal 2025. Expenses increased largely due to $19.3 million in added costs from the acquired business in our Water Treatment segment, including amortization of intangibles of $8.9 million, fair value accretion on the WaterSurplus earnout liability of $1.9 million, as well as increased variable costs. This was partially offset by a reduction of $8.1 million to the Water Solutions earnout.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended March 29, 2026, was $37.2 million, an increase of $0.2 million, or 1%, from adjusted EBITDA of $37.0 million for the same period in the prior year. Full-year adjusted EBITDA was $179.0 million, an increase of $10.2 million, or 6%, from adjusted EBITDA of $168.9 million for fiscal 2025. The increase was due to the impact of improved gross profits discussed above.

INCOME TAXES

Our effective tax rate was approximately 25% for fiscal 2026 and 26% for fiscal 2025. The current year decrease in the effective tax rate was primarily driven by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. For fiscal 2027, we expect the income tax rate to be between 25% to 27%.

## Financial statements

### Income Statement (Adjusted EBITDA (in thousands))

| | Three Months Ended – March 29, 2026 | Three Months Ended – March 30, 2025 | Fiscal Year Ended – March 29, 2026 | Fiscal Year Ended – March 30, 2025 |
|---|---:|---:|---:|---:|
| Net income (GAAP) | 15,463 | 16,327 | 81,548 | 84,345 |
| Interest expense, net | 2,972 | 1,526 | 13,507 | 5,432 |
| Income tax expense | 4,461 | 6,095 | 27,792 | 30,038 |
| Amortization of intangibles | 5,494 | 3,553 | 21,292 | 12,764 |
| Depreciation expense | 8,085 | 7,027 | 31,250 | 27,184 |
| Non-cash compensation expense | 2,135 | 1,476 | 8,573 | 6,498 |
| Non-recurring acquisition expense | 18 | 649 | 1,239 | 1,229 |
| Non-cash earnout related expense | -1,410 | 342 | -6,177 | 1,375 |
| Adjusted EBITDA | 37,218 | 36,995 | 179,024 | 168,865 |

### Income Statement (Three Months Ended — (In thousands, except share and per-share data))

| | Three Months Ended – March 29, 2026 – (unaudited) | Three Months Ended – March 30, 2025 – (unaudited) | Fiscal Year Ended – March 29, 2026 | Fiscal Year Ended – March 30, 2025 |
|---|---:|---:|---:|---:|
| Sales | 265,910 | 245,318 | 1,083,696 | 974,431 |
| Cost of sales | -211,673 | -193,081 | -838,641 | -748,893 |
| Gross profit | 54,237 | 52,237 | 245,055 | 225,538 |
| Selling, general and administrative expenses | -30,773 | -27,662 | -123,762 | -106,364 |
| Operating income | 23,464 | 24,575 | 121,293 | 119,174 |
| Interest expense, net | -2,972 | -1,526 | -13,507 | -5,432 |
| Other income (expense) | -568 | -627 | 1,554 | 641 |
| Income before income taxes | 19,924 | 22,422 | 109,340 | 114,383 |
| Income tax expense | -4,461 | -6,095 | -27,792 | -30,038 |
| Net income | 15,463 | 16,327 | 81,548 | 84,345 |
| Weighted average number of shares outstanding-basic | 20,751,747 | 20,728,528 | 20,736,815 | 20,803,872 |
| Weighted average number of shares outstanding-diluted | 20,870,810 | 20,848,118 | 20,861,860 | 20,936,502 |
| Basic earnings per share | 0.75 | 0.79 | 3.93 | 4.05 |
| Diluted earnings per share | 0.74 | 0.78 | 3.91 | 4.03 |

### Income Statement (Water Treatment — (In thousands) (in thousands))

| | Fiscal Year Ended March 29, 2026: – Water Treatment | Fiscal Year Ended March 29, 2026: – Food and Health Sciences | Fiscal Year Ended March 29, 2026: – Industrial Solutions | Fiscal Year Ended March 29, 2026: – Total |
|---|---:|---:|---:|---:|
| Sales | 543,303 | 320,700 | 219,693 | 1,083,696 |
| Cost of sales - materials | -327,821 | -233,960 | -174,415 | -736,196 |
| Cost of sales - operational overhead | -70,529 | -19,408 | -12,508 | -102,445 |
| Gross profit | 144,953 | 67,332 | 32,770 | 245,055 |
| Selling, general, and administrative expenses | -76,865 | -32,981 | -13,916 | -123,762 |
| Operating income | 68,088 | 34,351 | 18,854 | 121,293 |
| Fiscal Year Ended March 30, 2025: | Sales | 446,489 | 322,560 | 205,382 | 974,431 |
| Fiscal Year Ended March 30, 2025: | Cost of sales - materials | -259,722 | -231,621 | -160,199 | -651,542 |
| Fiscal Year Ended March 30, 2025: | Cost of sales - operational overhead | -64,934 | -19,021 | -13,396 | -97,351 |
| Fiscal Year Ended March 30, 2025: | Gross profit | 121,833 | 71,918 | 31,787 | 225,538 |
| Fiscal Year Ended March 30, 2025: | Selling, general, and administrative expenses | -62,287 | -30,720 | -13,357 | -106,364 |
| Fiscal Year Ended March 30, 2025: | Operating income | 59,546 | 41,198 | 18,430 | 119,174 |

### Balance Sheet (in thousands)

| |  |
|---|---:|
| Return on Equity | ($ in thousands) | Fiscal Year Ended March 29, 2026 |
| Return on Equity | Net income (GAAP) | 81,548 |
| Return on Equity | Shareholders' equity at beginning of period | 460,292 |
| Return on Equity | Shareholders' equity at end of period | 534,009 |
| Return on Equity | Average shareholders' equity | 497,151 |
| Return on Equity | Return on equity | 16.4 |

### Balance Sheet (March 29, 2026 — (In thousands, except share and per-share data))

| | March 29, 2026 | March 30, 2025 |
|---|---:|---:|
| CURRENT ASSETS: | Cash and cash equivalents | 3,914 | 5,103 |
| CURRENT ASSETS: | Trade accounts receivables, net | 139,796 | 131,795 |
| CURRENT ASSETS: | Inventories | 78,199 | 83,512 |
| CURRENT ASSETS: | Income taxes receivable | 891 | 2,864 |
| CURRENT ASSETS: | Prepaid expenses and other current assets | 8,665 | 7,417 |
| CURRENT ASSETS: | Total current assets | 231,465 | 230,691 |
| PROPERTY, PLANT, AND EQUIPMENT: | Land | 21,223 | 18,679 |
| PROPERTY, PLANT, AND EQUIPMENT: | Buildings and improvements | 193,210 | 163,913 |
| PROPERTY, PLANT, AND EQUIPMENT: | Machinery and equipment | 175,495 | 150,981 |
| PROPERTY, PLANT, AND EQUIPMENT: | Transportation equipment | 89,220 | 78,064 |
| PROPERTY, PLANT, AND EQUIPMENT: | Office furniture and equipment | 10,514 | 9,316 |
| PROPERTY, PLANT, AND EQUIPMENT: |  | 489,662 | 420,953 |
| PROPERTY, PLANT, AND EQUIPMENT: | Less accumulated depreciation | 223,406 | 195,667 |
| PROPERTY, PLANT, AND EQUIPMENT: | Net property, plant, and equipment | 266,256 | 225,286 |
| OTHER ASSETS: | Right-of-use assets | 16,840 | 13,449 |
| OTHER ASSETS: | Goodwill | 223,042 | 135,409 |
| OTHER ASSETS: | Intangible assets, net | 232,887 | 150,121 |
| OTHER ASSETS: | Deferred compensation plan assets | 12,812 | 11,185 |
| OTHER ASSETS: | Other assets | 2,988 | 3,907 |
| OTHER ASSETS: | Total other assets | 488,569 | 314,071 |
| OTHER ASSETS: | Total assets | 986,290 | 770,048 |
| CURRENT LIABILITIES: | Accounts payable — trade | 59,835 | 61,195 |
| CURRENT LIABILITIES: | Accrued payroll and employee benefits | 20,092 | 19,659 |
| CURRENT LIABILITIES: | Short-term lease liabilities | 3,000 | 2,900 |
| CURRENT LIABILITIES: | Contract liability | 1,580 |  |
| CURRENT LIABILITIES: | Accrued real estate taxes | 1,224 | 1,030 |
| CURRENT LIABILITIES: | Current portion of deferred compensation liability | 1,334 | 538 |
| CURRENT LIABILITIES: | Container deposits | 1,383 | 1,914 |
| CURRENT LIABILITIES: | Current portion of earnout liability | 4,529 |  |
| CURRENT LIABILITIES: | Environmental remediation | 7,700 | 7,700 |
| CURRENT LIABILITIES: | Other current liabilities | 4,167 | 2,286 |
| CURRENT LIABILITIES: | Total current liabilities | 104,844 | 97,222 |

### Balance Sheet (March 29, 2026 — (In thousands, except share and per-share data))

| | March 29, 2026 | March 30, 2025 |
|---|---:|---:|
| LONG-TERM LIABILITIES: | Long-term debt | 244,000 | 149,000 |

### Cash Flow (Fiscal Year Ended — (In thousands) (in thousands))

| | Fiscal Year Ended – March 29, 2026 | Fiscal Year Ended – March 30, 2025 |
|---|---:|---:|
| CASH FLOWS FROM OPERATING ACTIVITIES: | Net income | 81,548 | 84,345 |
| Reconciliation to cash flows: | Depreciation and amortization | 52,542 | 39,948 |
| Reconciliation to cash flows: | Change in fair value of earnout liability | -6,177 | 1,369 |
| Reconciliation to cash flows: | Operating leases | 3,982 | 3,475 |
| Reconciliation to cash flows: | Gain on deferred compensation assets | -1,554 | -641 |
| Reconciliation to cash flows: | Deferred income taxes | 3,053 | 461 |
| Reconciliation to cash flows: | Stock compensation expense | 8,573 | 6,498 |
| Reconciliation to cash flows: | Gain from asset disposals | -202 | -61 |
| Reconciliation to cash flows: | Other, net | 179 | 87 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Trade receivables | -2,467 | -11,230 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Inventories | 10,053 | -6,572 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Accounts payable | -5,841 | 2,445 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Accrued liabilities | 2,195 | 476 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Lease liabilities | -3,775 | -3,468 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Income taxes | 2,071 | -4,807 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Other, net | 147 | -1,229 |
| Changes in operating accounts (using) providing cash, net of acquisitions: | Net cash provided by operating activities | 144,327 | 111,096 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Additions to property, plant, and equipment | -58,239 | -41,096 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Acquisitions | -167,108 | -87,400 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Proceeds from asset disposals | 1,248 | 544 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | Net cash used in investing activities | -224,099 | -127,952 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Cash dividends paid | -15,665 | -14,635 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ESPP shares issued | 3,040 | 2,658 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Shares surrendered for payroll taxes | -3,028 | -2,541 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Shares repurchased |  | -20,676 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Payments for debt issuance costs | -764 |  |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Payments on senior secured revolving loan | -75,000 | -60,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Borrowings on senior secured revolving loan | 170,000 | 110,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | Net cash provided by (used in) financing activities | 78,583 | 14,806 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | NET DECREASE IN CASH AND CASH EQUIVALENTS | -1,189 | -2,050 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | CASH AND CASH EQUIVALENTS - beginning of year | 5,103 | 7,153 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | CASH AND CASH EQUIVALENTS - end of year | 3,914 | 5,103 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION- | Cash paid during the year for income taxes, net of refunds | 22,685 | 34,386 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION- | Cash paid for interest | 13,650 | 5,785 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION- | Noncash investing activities - Capital expenditures in accounts payable | 2,536 | 1,841 |
